Literature DB >> 15844140

Imaging of single human carcinoma cells in vitro using a clinical whole-body magnetic resonance scanner at 3.0 T.

Jens Pinkernelle1, Ulf Teichgräber, Fabian Neumann, Lukas Lehmkuhl, Jens Ricke, Regina Scholz, Andreas Jordan, Harald Bruhn.   

Abstract

The purpose of the present study was to examine whether single human carcinoma cells labeled with iron oxide nanoparticles could be detected by magnetic resonance (MR) imaging on a clinical 3-T scanner using a surface coil only. WiDr human colon carcinoma cells were loaded with two kinds of iron oxide nanoparticles differing by coating and size: aminosilan-coated (MagForce) and carboxy-dextran-coated particles (Resovist). The latter were preferred by the colon carcinoma cell line used here and taken up much faster (12 h) than the smaller carboxydextran-coated Resovist (48 h). Labeled single carcinoma cells, distributed in an agarose gel in a monodisperse layer as controlled by light microscopy, became detectable as punctuate signal extinctions when using a small circularly polarized surface coil in conjunction with a T(2)*-weighted GE sequence at 3 T. The threshold for the detectability of labeled colon carcinoma cells ranged at a load of 4-5 mug iron/10(6) cells. Obviating the need for special hardware additions, this study opens a new lane for single-cell tracking on clinical 3-T MR scanners amenable to patient studies. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15844140     DOI: 10.1002/mrm.20455

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  8 in total

1.  Effect of spatial distribution of magnetic dipoles on Lamor frequency distribution and MR Signal decay--a numerical approach under static dephasing conditions.

Authors:  J Pintaske; B Müller-Bierl; F Schick
Journal:  MAGMA       Date:  2006-02-10       Impact factor: 2.310

2.  Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging.

Authors:  Lars Stelter; Jens G Pinkernelle; Roger Michel; Ruth Schwartländer; Nathanael Raschzok; Mehmet H Morgul; Martin Koch; Timm Denecke; Juri Ruf; Hans Bäumler; Andreas Jordan; Bernd Hamm; Igor M Sauer; Ulf Teichgräber
Journal:  Mol Imaging Biol       Date:  2009-07-07       Impact factor: 3.488

3.  Magnetic resonance imaging of cells in experimental disease models.

Authors:  Naser Muja; Jeff W M Bulte
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2009-07       Impact factor: 9.795

4.  Dual-imaging enabled cancer-targeting nanoparticles.

Authors:  Aniket S Wadajkar; Tejaswi Kadapure; Yi Zhang; Weina Cui; Kytai T Nguyen; Jian Yang
Journal:  Adv Healthc Mater       Date:  2012-07       Impact factor: 9.933

5.  Multifunctional particles for melanoma-targeted drug delivery.

Authors:  Aniket S Wadajkar; Zarna Bhavsar; Cheng-Yu Ko; Bhanuprasanth Koppolu; Weina Cui; Liping Tang; Kytai T Nguyen
Journal:  Acta Biomater       Date:  2012-05-03       Impact factor: 8.947

6.  CARS microscopy for the visualization of micrometer-sized iron oxide MRI contrast agents in living cells.

Authors:  Gianluca Rago; Carolin M Langer; Christian Brackman; James P R Day; Katrin F Domke; Nathanael Raschzok; Christian Schmidt; Igor M Sauer; Annika Enejder; Martina T Mogl; Mischa Bonn
Journal:  Biomed Opt Express       Date:  2011-07-29       Impact factor: 3.732

Review 7.  Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy.

Authors:  Xiang-Hong Peng; Ximei Qian; Hui Mao; Andrew Y Wang; Zhuo Georgia Chen; Shuming Nie; Dong M Shin
Journal:  Int J Nanomedicine       Date:  2008

8.  Imaging of primary human hepatocytes performed with micron-sized iron oxide particles and clinical magnetic resonance tomography.

Authors:  Nathanael Raschzok; Mehmet H Morgul; Jens Pinkernelle; Florian W R Vondran; Nils Billecke; Nora N Kammer; Gesine Pless; Michaela K Adonopoulou; Christian Leist; Lars Stelter; Ulf Teichgraber; Ruth Schwartlander; Igor M Sauer
Journal:  J Cell Mol Med       Date:  2008-04-09       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.